Patents by Inventor Xiping Liu

Xiping Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11003001
    Abstract: A method for manufacturing a display substrate, a method for manufacturing a display panel, and a display panel are disclosed. The method for manufacturing a display substrate includes: providing a base substrate, in which the base substrate includes a first surface and a second surface which are opposite to each other; reducing a thickness of the base substrate from the first surface by way of a thinning process; and forming a first protective layer on the first surface obtained after thinning by a tape casting method.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: May 11, 2021
    Assignees: BOE Technology Group Co., Ltd., Hefei Xinsheng Optoelectronics Technology Co., Ltd.
    Inventors: Haifeng Liu, Xiaoye Ma, Xiping Wang
  • Patent number: 10401949
    Abstract: The present disclosure relates to virtual reality glasses. The virtual reality glasses include a glasses body The glasses body includes a first surface towards a user's face and a second surface configured to have an external electronic device mounted thereon for playing virtual reality contents The virtual reality glasses further include a fastening structure configured to fasten the external electronic device to the second surface. The fastening structure includes a connector fastener having a built-in connector which is connectable to an interface at a first end of the external electronic device, and at least one device fastener configured to fasten a second end of the external electronic device.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: September 3, 2019
    Assignee: Beijing Xiaomi Mobile Software Co., Ltd.
    Inventors: Hao Jiang, Zheng Zhang, Yujie Jiang, Renlu Peng, Xiping Liu, Wenhui Ding
  • Publication number: 20180059776
    Abstract: The present disclosure relates to virtual reality glasses. The virtual reality glasses include a glasses body The glasses body includes a first surface towards a user's face and a second surface configured to have an external electronic device mounted thereon for playing virtual reality contents The virtual reality glasses further include a fastening structure configured to fasten the external electronic device to the second surface. The fastening structure includes a connector fastener having a built-in connector which is connectable to an interface at a first end of the external electronic device, and at least one device fastener configured to fasten a second end of the external electronic device.
    Type: Application
    Filed: August 15, 2017
    Publication date: March 1, 2018
    Inventors: Hao JIANG, Zheng ZHANG, Yujie JIANG, Renlu PENG, Xiping LIU, Wenhui DING
  • Patent number: 9193782
    Abstract: The invention provides multiparametric anti-SPARC antibody-based techniques for predicting the response to chemotherapy.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: November 24, 2015
    Assignee: Abraxis BioScience, LLC
    Inventors: Vuong Trieu, Xiping Liu, Neil Desai
  • Patent number: 9096660
    Abstract: The invention provides SPARC binding antibodies that target disease sites, in particular, tumors and uses thereof to diagnose and treat diseases, in particular, cancerous tumors.
    Type: Grant
    Filed: April 26, 2011
    Date of Patent: August 4, 2015
    Assignee: Abraxis BioScience, LLC
    Inventors: Vuong Trieu, Xiping Liu, Neil Desai
  • Publication number: 20130281376
    Abstract: The invention provides multiparametric anti-SPARC antibody-based techniques for treating cancers as well as determining prognosis and predicting the response to therapy, including chemotherapy, radiotherapy, surgical therapy and combination therapies.
    Type: Application
    Filed: October 7, 2011
    Publication date: October 24, 2013
    Applicant: ABRAXIS BIOSCIENCE, LLC
    Inventors: Vuong Trieu, Larn Hwang, Kouros Motamed, Xiping Liu, Neil Desai
  • Publication number: 20130101504
    Abstract: The invention provides SPARC binding antibodies that target disease sites, in particular, tumors and uses thereof to diagnose and treat diseases, in particular, cancerous tumors.
    Type: Application
    Filed: April 26, 2011
    Publication date: April 25, 2013
    Applicant: ABRAXIS BIOSCIENCE, LLC
    Inventors: Vuong Trieu, Xiping Liu, Neil Desai
  • Publication number: 20120148613
    Abstract: The present invention provides a method of treating a cell proliferative disease such as cancer by providing to a subject in need thereof an immunogenic composition comprising plasmid and peptide(s) or analogues thereof. In embodiments of the present invention there is provided methods and compositions for inducing, entraining, and/or amplifying the immune response to MHC class-I restricted epitopes of carcinoma antigens to generate an effective anti-cancer immune response.
    Type: Application
    Filed: December 23, 2011
    Publication date: June 14, 2012
    Applicant: MannKind Corporation
    Inventors: Adrian Ion Bot, Chih-Sheng Chiang, David C. Diamond, Jian Gong, Kent Andrew Smith, Liping Liu, Xiping Liu, Zhiyong Qiu
  • Publication number: 20120052007
    Abstract: The invention provides SPARC binding antibodies that have high affinity to SPARC, particularly plasma SPARC, and methods of using such antibodies in treating conditions including cancer.
    Type: Application
    Filed: June 3, 2011
    Publication date: March 1, 2012
    Applicant: ABRAXIS BIOSCIENCE, LLC
    Inventors: Vuong Trieu, Xiping Liu, Neil Desai
  • Publication number: 20120020959
    Abstract: The invention provides multiparametric anti-SPARC antibody-based techniques for predicting the response to chemotherapy.
    Type: Application
    Filed: June 3, 2011
    Publication date: January 26, 2012
    Applicant: ABRAXIS BIOSCIENCE, LLC
    Inventors: Vuong Trieu, Xiping Liu, Neil Desai
  • Patent number: 8084592
    Abstract: The present invention provides a method of treating a cell proliferative disease such as cancer by providing to a subject in need thereof an immunogenic composition comprising plasmid and peptide(s) or analogues thereof. In embodiments of the present invention there is provided methods and compositions for inducing, entraining, and/or amplifying the immune response to MHC class-I restricted epitopes of carcinoma antigens to generate an effective anti-cancer immune response.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: December 27, 2011
    Assignee: MannKind Corporation
    Inventors: Adrian Ion Bot, Chih-Sheng Chiang, David C. Diamond, Jian Gong, Kent Andrew Smith, Liping Liu, Xiping Liu, Zhiyong Qiu
  • Publication number: 20070003563
    Abstract: The present invention provides a method of treating a cell proliferative disease such as cancer by providing to a subject in need thereof an immunogenic composition comprising plasmid and peptide(s) or analogues thereof. In embodiments of the present invention there is provided methods and compositions for inducing, entraining, and/or amplifying the immune response to MHC class-I restricted epitopes of carcinoma antigens to generate an effective anti-cancer immune response.
    Type: Application
    Filed: June 16, 2006
    Publication date: January 4, 2007
    Inventors: Adrian Bot, Chih-Sheng Chiang, David Diamond, Jian Gong, Kent Smith, Liping Liu, Xiping Liu, Zhiyong Qiu
  • Publication number: 20060165711
    Abstract: Embodiments relate to methods and compositions for eliciting, enhancing, and sustaining immune responses, preferably multivalent responses, preferably against MHC class I-restricted epitopes. The methods and compositions can be used for prophylactic or therapeutic purposes.
    Type: Application
    Filed: December 29, 2005
    Publication date: July 27, 2006
    Inventors: Adrian Bot, Xiping Liu, Kent Smith
  • Publication number: 20060159694
    Abstract: Disclosed herein are methods and compositions for inducing an immune response against various combinations of tumor-associated antigens, which can promote effective immunologic intervention in pathogenic processes. Embodiments of the invention disclosed herein are directed to the use of effective combinations of TuAAs for the immunotherapy of patients with various types of cancer. Both immunogenic compositions for inducing an immune response to these combinations of antigens and methods for their use are disclosed.
    Type: Application
    Filed: December 29, 2005
    Publication date: July 20, 2006
    Inventors: Chih-Sheng Chiang, John Simard, David Diamond, Adrian Bot, Xiping Liu
  • Publication number: 20060159689
    Abstract: Disclosed herein are methods for matching a cancer condition with an appropriate immunotherapeutic agent and/or regimen. Also disclosed are methods for confirming diagnosis of a particular type of cancer. Embodiments of the invention disclosed herein are directed to the use of effective combinations of TuAAs to optimize the match between a patient's cancer condition and available immunotherapies.
    Type: Application
    Filed: December 29, 2005
    Publication date: July 20, 2006
    Inventors: Chih-Sheng Chiang, John Simard, David Diamond, Adrian Bot, Xiping Liu
  • Publication number: 20060042557
    Abstract: A small intelligent hatcher comprising a shell body with a supporting shelf; an egg container, a rolling device, a heating device and a control circuitry are on the supporting shelf; the rolling device further consists of a transmission and a motor; the egg container is on the top of the output axis of the transmission, the back of the output axis of the transmission connects to a limitation indicator, two limitation switches each is on one end of the limitation indicator and connects to the control circuitry to control the rolling direction and angle of the motor; the heating device and the fan connect to the control circuitry to control the temperature; an observation window is on the front of the shell body is suitable for children to observe and record.
    Type: Application
    Filed: August 25, 2004
    Publication date: March 2, 2006
    Applicant: Xiping Liu
    Inventors: Xiping Liu, Zhenhua Tao
  • Publication number: 20050079152
    Abstract: Embodiments relate to methods and compositions for eliciting, enhancing, and sustaining immune responses, preferably against MHC class I-restricted epitopes. The methods and compositions can be used for prophylactic or therapeutic purposes.
    Type: Application
    Filed: June 17, 2004
    Publication date: April 14, 2005
    Inventors: Adrian Bot, Xiping Liu, Kent Smith